• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Need for better reporting of trials with surrogate endpoints: SPIRIT|CONSORT-SURROGATE extensions.

作者信息

Ciani Oriana, Manyara Anthony, Taylor Rod S

机构信息

SDA Bocconi School of Management, Milano, Italy.

MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Glasgow, UK.

出版信息

J Epidemiol Community Health. 2022 Jun 24;76(9):769-70. doi: 10.1136/jech-2022-219294.

DOI:10.1136/jech-2022-219294
PMID:35750481
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9380472/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4b6/9380472/8c79360985ad/jech-2022-219294f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4b6/9380472/8c79360985ad/jech-2022-219294f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4b6/9380472/8c79360985ad/jech-2022-219294f01.jpg

相似文献

1
Need for better reporting of trials with surrogate endpoints: SPIRIT|CONSORT-SURROGATE extensions.需要更好地报告采用替代终点的试验：SPIRIT|CONSORT-SURROGATE扩展版
J Epidemiol Community Health. 2022 Jun 24;76(9):769-70. doi: 10.1136/jech-2022-219294.
2
Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE.用于具有替代主要终点的随机对照试验的 SPIRIT 和 CONSORT 扩展的制定方案：SPIRIT-SURROGATE 和 CONSORT-SURROGATE。
BMJ Open. 2022 Oct 11;12(10):e064304. doi: 10.1136/bmjopen-2022-064304.
3
Scoping and targeted reviews to support development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: protocol.范围界定和针对性综述，以支持具有替代主要终点的随机对照试验的 SPIRIT 和 CONSORT 扩展的制定：方案。
BMJ Open. 2022 Oct 13;12(10):e062798. doi: 10.1136/bmjopen-2022-062798.
4
Mixed-methods study to develop extensions to the SPIRIT and CONSORT statements for factorial randomised trials: the Reporting Factorial Trials (RAFT) study.一项混合方法研究，旨在为析因随机试验开发SPIRIT和CONSORT声明的扩展内容：析因试验报告（RAFT）研究。
BMJ Open. 2025 Feb 17;15(2):e082917. doi: 10.1136/bmjopen-2023-082917.
5
Transparent and complete reporting of surrogate endpoints in trials: the SPIRIT-Surrogate and CONSORT-Surrogate extensions.试验中替代终点的透明与完整报告：SPIRIT-替代终点和CONSORT-替代终点扩展版
Lancet. 2024 Jul 27;404(10450):322-324. doi: 10.1016/S0140-6736(24)01306-0. Epub 2024 Jul 11.
6
Surrogate endpoints in trials: a call for better reporting.临床试验中的替代终点：提高报告质量的呼吁。
Trials. 2022 Dec 12;23(1):991. doi: 10.1186/s13063-022-06904-7.
7
Guidelines for reporting pediatric and child health clinical trial protocols and reports: study protocol for SPIRIT-Children and CONSORT-Children.儿科和儿童健康临床试验方案和报告报告指南：SPIRIT-Children 和 CONSORT-Children 的研究方案。
Trials. 2024 Jan 30;25(1):96. doi: 10.1186/s13063-024-07948-7.
8
A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials.一项关于在干预性试验中替代终点使用的定义与解释的框架。
EClinicalMedicine. 2023 Oct 17;65:102283. doi: 10.1016/j.eclinm.2023.102283. eCollection 2023 Nov.
9
A call for transparency, improved reporting, and interpretation of trials using surrogate end points in cardiac electrophysiology.呼吁在心脏电生理学中使用替代终点的试验实现透明化、改进报告及解读。
Heart Rhythm. 2025 Aug;22(8):e492-e499. doi: 10.1016/j.hrthm.2025.02.038. Epub 2025 Feb 26.
10
Reminding Peer Reviewers of Reporting Guideline Items to Improve Completeness in Published Articles: Primary Results of 2 Randomized Trials.提醒同行评审员注意报告指南条目，以提高已发表文章的完整性：两项随机试验的主要结果。
JAMA Netw Open. 2023 Jun 1;6(6):e2317651. doi: 10.1001/jamanetworkopen.2023.17651.

引用本文的文献

1
Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate): extension checklist with explanation and elaboration.随机对照试验报告中替代终点的报告（CONSORT-Surrogate）：扩展清单及解释和说明。
BMJ. 2024 Jul 9;386:e078524. doi: 10.1136/bmj-2023-078524.
2
Reporting of surrogate endpoints in randomised controlled trial protocols (SPIRIT-Surrogate): extension checklist with explanation and elaboration.随机对照试验方案中替代终点报告（SPIRIT-Surrogate）：扩展清单及说明和阐述。
BMJ. 2024 Jul 9;386:e078525. doi: 10.1136/bmj-2023-078525.
3
Effects of Niaoduqing granules on inflammatory response of diabetic kidney disease: A meta‑analysis.

本文引用的文献

1
Immediate effects of a very brief planning intervention on fruit and vegetable consumption: A randomized controlled trial.一项非常简短的规划干预对水果和蔬菜消费的即时影响：一项随机对照试验。
Appl Psychol Health Well Being. 2021 May;13(2):377-393. doi: 10.1111/aphw.12254. Epub 2021 Feb 4.
2
A Systematic Review and Recommendation for Reporting of Surrogate Endpoint Evaluation Using Meta-analyses.一项关于使用荟萃分析报告替代终点评估的系统评价与建议
JNCI Cancer Spectr. 2019 Feb 6;3(1):pkz002. doi: 10.1093/jncics/pkz002. eCollection 2019 Mar.
3
Randomised controlled trials - the gold standard for effectiveness research: Study design: randomised controlled trials.
尿毒清颗粒对糖尿病肾病炎症反应的影响：一项荟萃分析。
Exp Ther Med. 2023 Sep 6;26(4):494. doi: 10.3892/etm.2023.12193. eCollection 2023 Oct.
4
Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE.用于具有替代主要终点的随机对照试验的 SPIRIT 和 CONSORT 扩展的制定方案：SPIRIT-SURROGATE 和 CONSORT-SURROGATE。
BMJ Open. 2022 Oct 11;12(10):e064304. doi: 10.1136/bmjopen-2022-064304.
随机对照试验——有效性研究的金标准：研究设计：随机对照试验
BJOG. 2018 Dec;125(13):1716. doi: 10.1111/1471-0528.15199. Epub 2018 Jun 19.
4
Time to Review the Role of Surrogate End Points in Health Policy: State of the Art and the Way Forward.是时候审视替代终点在卫生政策中的作用了：现状与未来方向。
Value Health. 2017 Mar;20(3):487-495. doi: 10.1016/j.jval.2016.10.011. Epub 2016 Dec 22.
5
Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study.比较随机对照试验中替代和最终与患者相关结局的治疗效果大小：Meta 流行病学研究。
BMJ. 2013 Jan 29;346:f457. doi: 10.1136/bmj.f457.
6
SPIRIT 2013 statement: defining standard protocol items for clinical trials.SPIRIT 2013 声明：定义临床试验的标准议定书项目。
Ann Intern Med. 2013 Feb 5;158(3):200-7. doi: 10.7326/0003-4819-158-3-201302050-00583.
7
'Hard,' 'soft' and 'surrogate' endpoints in diabetes.糖尿病中的“硬”终点、“软”终点及“替代”终点
J Epidemiol Community Health. 2013 Apr;67(4):295-7. doi: 10.1136/jech-2012-201361. Epub 2012 Nov 21.
8
Rosiglitazone: what went wrong?罗格列酮：问题出在哪里？
BMJ. 2010 Sep 6;341:c4848. doi: 10.1136/bmj.c4848.
9
Inconsistent reporting of surrogate outcomes in randomised clinical trials: cohort study.随机临床试验中替代结局报告的不一致性：队列研究。
BMJ. 2010 Aug 18;341:c3653. doi: 10.1136/bmj.c3653.
10
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.CONSORT 2010 声明：平行组随机试验报告的更新指南。
BMJ. 2010 Mar 23;340:c332. doi: 10.1136/bmj.c332.